Ningxia Center for Disease Control and Prevention | China
Author Profile
Scopus
Orcid
🌱 Early Academic Pursuits
Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.
💼 Professional Endeavors
Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:
-
➤ Director, National AIDS Prevention and Control Association
-
➤ Member, National AIDS Testing Committee
-
➤ Member, National Microbial Sequencing Technical Committee
-
➤ Member, Ningxia Immunology Society
-
➤ Editorial Board Member, Journal of Phenomics
Her leadership spans laboratory diagnostics, public health strategy, and national policy.
🔬 Contributions and Research Focus
Prof. Wu’s scientific contributions are rooted in two major domains:
🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.
🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundation, returnee innovation grants, and key R&D initiatives in Ningxia.
🏆 Accolades and Recognition
Prof. Wu has garnered widespread acclaim, including:
-
➤ National Public Health Leading Talent Program (2024)
-
➤ “Advanced Worker” of the Autonomous Region (2025)
-
➤ Ningxia Young Top Talent Cultivation Program (2017)
Her team’s achievements have been celebrated with:
-
➤ Third Prize for Scientific and Technological Progress (2019, 2023)
-
➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards
🌍 Impact and Influence
Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.
📚 Legacy and Future Contributions
Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.
Publications
📄 Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China
Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025
📄 HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China
Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025
📄 Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021
Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025
📄 Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023
Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025
📄 Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis
Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016